New Policy Review:

Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology thelancet.com/journals/lanon…

Gearing up for #ESTRO24 with fantastic cycling tour

Weniger Schmerzen bei Metastasen in der Wirbelsäule durch Präzisions-Strahlentherapie:
usz.ch/weniger-schmer…

Unispital_USZ Comprehensive Cancer Center Zurich

Celebrate a decade of “MReadings: MR in RT” with our 10th Edition! With an editorial comment by Stephanie Tanadini-Lang and Matthias Guckenberger (@Unispital_USZ) on Next-Generation #MRI -Guided #Radiotherapy .
Learn more at …ng.webassets.siemens-healthineers.com/3b9e41eefac69d…

#magnetomworld #MRinRT #ESTRO2024 Siemens Healthineers

Relevant survey 👇

A nationwide Dutch study (ESLUNG) demonstrates similar OS for stage I NSCLC treated with Lobectomy or SABR (HR 0.89, 95 % CI 0.65–1.20). #radonc #CSP2005 sciencedirect.com/science/articl…

Outstanding #BTOG24 meeting led by the wonderful ⁦Sanjay Popat⁩ ⁦BTOG⁩

Looking forward to lots of interdisciplinary exchange at #BETOG2024 meeting in Belfast

📗 The abstract book for #ESTRO24 is now online! Access the latest #research in #RadiationOncology to be presented at the congress:
👉bit.ly/49y1iJm
#radonc #radiotherapy #innovations

Let's take your mind on a walk outside the box.
Phase I Clinical Trial of SBRT for Lung Volume Reduction for Severe Emphysema
Max Diehn, MD/PhD Bill Loo MD PhD ⚡️☢️ Stanford Radiation Oncology
At: redjournal.org/article/S0360-…

Diagnostic CT-Enabled Planning (DART) for palliative RT
👉 Time in center reduced from 4.7h to 0.4h
👉 Highly relevant study to reduce efforts for palliative patients while maintaining radiotherapy quality
👏 Melissa O'Neil Dr. David Palma and study team
redjournal.org/article/S0360-…

Hi 🫁 #LCSM peeps! A quick interview with the The Lancet podcast team gives some more insight into the SEISMIC 🫨trial outcomes ➡️
🔊Listen here: tinyurl.com/ynkkj39y

#radonc #lungcancer

The vast offering of #ESTRO24 can be overwhelming! Need help picking sessions, or flexing your networking muscles? ESTRO is introducing 'scientific journeys' to help! Topics include #AI , positioning and specific clinical diagnoses #medphys #radonc #rtt . See you in Glasgow!

New article alert (Vol. 195)

Cancer-specific dose and fractionation schedules in sbrt for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study
Sebastian M. Christ et al.

doi.org/10.1016/j.rado…

thegreenjournal.com/article/S0167-…